Boston Scientific is investing in new technologies across all areas of the Company, resulting in an award-winning patent portfolio that is well recognized in the industry. The Company is consistently expanding investment in new technology, which supports our mission of “Delivering What’s Next” in less-invasive therapies.
In addition to the Company’s internal investments, Boston Scientific is committed to investing in external, or acquired, R&D through acquisitions and investments in new businesses. Boston Scientific’s rate of investment actually exceeds most of our peers in the medical device industry, and is spread out across all our businesses.
We will continue to invest heavily in our collective futures by developing less-invasive products and procedures, and through the acquisition of new technologies that will better enable physicians to treat their patients.
| * 2007 figures include internal R&D investments and U.S. patents from five businesses divested in late 2007 and early 2008. |
At year-end 2009: 10,009 applications pending worldwide
|
